Use of real‐world evidence in regulatory decisions for rare diseases in the United States—Current status and future directions
2020 ◽
Vol 29
(10)
◽
pp. 1213-1218
◽
Keyword(s):
2019 ◽
Vol 40
(3-4)
◽
pp. 331-335
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
2016 ◽
Vol 32
(12)
◽
pp. 2047-2053
◽